[HTML][HTML] What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2
The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
has caused more than 1 million deaths in the first 6 months of the pandemic and huge …
has caused more than 1 million deaths in the first 6 months of the pandemic and huge …
Antibody tests for identification of current and past infection with SARS‐CoV‐2
T Fox, J Geppert, J Dinnes, K Scandrett… - Cochrane database …, 2022 - cochranelibrary.com
Background The diagnostic challenges associated with the COVID‐19 pandemic resulted in
rapid development of diagnostic test methods for detecting SARS‐CoV‐2 infection. Serology …
rapid development of diagnostic test methods for detecting SARS‐CoV‐2 infection. Serology …
Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis
ML Bastos, G Tavaziva, SK Abidi, JR Campbell… - bmj, 2020 - bmj.com
Objective To determine the diagnostic accuracy of serological tests for coronavirus disease-
2019 (covid-19). Design Systematic review and meta-analysis. Data sources Medline …
2019 (covid-19). Design Systematic review and meta-analysis. Data sources Medline …
SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys
PC Hallal, FP Hartwig, BL Horta, MF Silveira… - The Lancet Global …, 2020 - thelancet.com
Background Population-based data on COVID-19 are essential for guiding policies. There
are few such studies, particularly from low or middle-income countries. Brazil is currently a …
are few such studies, particularly from low or middle-income countries. Brazil is currently a …
[HTML][HTML] Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases
A Vojdani, D Kharrazian - Clinical Immunology (Orlando, Fla.), 2020 - ncbi.nlm.nih.gov
Since the outbreak of COVID-19 caused by SARS-CoV-2, we tested 5 different blood
specimens that were confirmed positive for SARS-CoV-2 IgG and IgM antibodies [1]. The …
specimens that were confirmed positive for SARS-CoV-2 IgG and IgM antibodies [1]. The …
Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review
E Ortiz-Prado, K Simbaña-Rivera… - … and infectious disease, 2020 - Elsevier
Coronaviruses are an extensive family of viruses that can cause disease in both animals
and humans. The current classification of coronaviruses recognizes 39 species in 27 …
and humans. The current classification of coronaviruses recognizes 39 species in 27 …
Humoral responses and serological assays in SARS-CoV-2 infections
Y Galipeau, M Greig, G Liu, M Driedger… - Frontiers in …, 2020 - frontiersin.org
In December 2019, the novel betacoronavirus Severe Acute Respiratory Disease
Coronavirus 2 (SARS-CoV-2) was first detected in Wuhan, China. SARS-CoV-2 has since …
Coronavirus 2 (SARS-CoV-2) was first detected in Wuhan, China. SARS-CoV-2 has since …
The spectrum of COVID-19–associated dermatologic manifestations: An international registry of 716 patients from 31 countries
EE Freeman, DE McMahon, JB Lipoff… - Journal of the American …, 2020 - Elsevier
Background Coronavirus disease 2019 (COVID-19) has associated cutaneous
manifestations. Objective To characterize the diversity of cutaneous manifestations of COVID …
manifestations. Objective To characterize the diversity of cutaneous manifestations of COVID …
[HTML][HTML] Evaluation of a novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples
L Porte, P Legarraga, V Vollrath, X Aguilera… - International Journal of …, 2020 - Elsevier
Objectives In the context of the coronavirus disease 2019 (COVID-19) pandemic, the
development and validation of rapid and easy-to-perform diagnostic methods are of high …
development and validation of rapid and easy-to-perform diagnostic methods are of high …
The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection
P Kellam, W Barclay - Journal of General Virology, 2020 - microbiologyresearch.org
SARS-CoV-2 is a novel coronavirus that is the causative agent of coronavirus infectious
disease 2019 (COVID-19). As of 17 April 2020, it has infected 2 114 269 people, resulting in …
disease 2019 (COVID-19). As of 17 April 2020, it has infected 2 114 269 people, resulting in …